EW Common Stock · Transaction May 27, 2026 · Filed Jun 9, 2026 · $1,001 to $15,000
Edwards Lifesciences Corp
Veridion Score
BETAHIGH CONF · 6/6 factorsComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is EW moving today?
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
EW overview
Related filings and maps
Congress activity in EW
EW Common Stock · Transaction May 15, 2026 · Filed Jun 9, 2026 · $1,001 to $15,000
EW Common Stock · Transaction May 1, 2026 · Filed Jun 9, 2026 · $1,001 to $15,000
EW Common Stock · Transaction Apr 24, 2026 · Filed May 11, 2026 · $1,001 to $15,000
EW Common Stock · Transaction Apr 13, 2026 · Filed May 11, 2026 · $1,001 to $15,000
EW contract awards, year to date.
Public federal awards linked to this ticker.
EW lobbying filings, year to date.
Registered lobbying filings matched to Edwards Lifesciences Corp.